Wegovy and Zepbound have dominated the medical weight loss conversation, but researchers are also studying new medications that may support weight loss in different ways
GLP-1 RAs are currently being explored for use in various new areas, such as cardiovascular disease, non-alcoholic steatohepatitis (NASH), Alzheimer's disease, and chronic kidney disease
While these may not be the only way to prevent tendon injuries associated with GLP-1 receptor agonists, they are the best methods that we know of at this juncture
Our guests enjoy the convenience of state-of-the-art care in a comfortable, luxury setting
[DOI] [PubMed] [Google Scholar] 68.Ontkean M., Gay R., Greenberg B
Adipose-derived stem cells induce autophagic activation and inhibit catabolic response to pro-inflammatory cytokines in rat chondrocytes